A Korean injectable lipolysis product for non-surgical body contouring and localized fat reduction — not a filler or skin booster.
DR. LIPO (Dr. Lipo+) is a lipolytic injection formulated to break down localized subcutaneous fat deposits through a combination of phosphatidylcholine (PPC), sodium deoxycholate, peptides, amino acids, and vitamins. It's intended for reducing stubborn fat in areas such as the chin, abdomen, thighs, arms, and flanks, and is distributed internationally through Korean medical aesthetic suppliers and clinics.
After injection into subcutaneous fat, phosphatidylcholine (PPC) helps disrupt fat cell membranes while sodium deoxycholate (DC) emulsifies and breaks them down further. The destroyed fat cells are gradually cleared through the body's lymphatic and metabolic systems, while added peptides and vitamins aim to support collagen production, skin firmness, and tissue recovery.
Body contouring — abdomen, flanks, thighs, upper arms, back fat. 10 vials × 10 mL
Facial fat reduction — double chin, jawline, lower cheeks, jowls, with added skin-supporting peptides and vitamins
Typical treatment involves 3–8 sessions, spaced approximately 2–4 weeks apart. The number of sessions depends on the treatment area, the amount of localized fat, and individual response — visible improvement is usually gradual over several weeks after each session.
Because these risks exist with any injectable or energy-based treatment, procedures should only be performed by trained, licensed medical professionals with expertise in facial anatomy.
DR. LIPO is distributed internationally through Korean aesthetic suppliers. Regulatory approval varies significantly by country, and the product is not approved by the U.S. FDA for cosmetic fat reduction — clinics should confirm compliance with local regulatory requirements before use.
DR. LIPO is positioned as a non-surgical fat-dissolving injectable rather than a dermal filler or collagen biostimulator, primarily used for reducing localized fat deposits and refining facial or body contours through PPC- and deoxycholate-based lipolysis. It combines lipolytic agents with peptides and vitamins aimed at enhancing skin quality, though high-quality, peer-reviewed clinical evidence specifically evaluating DR. LIPO remains limited. Outcomes depend on appropriate patient selection, realistic expectations, and treatment by experienced medical professionals.
